Genetic polymorphisms study of pharmacogenomic VIP variants in Han ethnic of China’s Shaanxi province

• Little information is about the systematically screen pharmacogenes of Han ethnic.
• We found frequency distribution of Han population in Shaanxi is similar with CHB.
• Structure and Fst showed Shaanxi Han have a closest genetic background with CHB.
• Our study have supplemented the Han Chinese data related to pharmacogenomics.

BackgroundMultiple factors include genetic and non-genetic interactions induce to different drug response among different individuals. Lots of researches proved that different frequencies of genetic variants exists different ethnic groups. The aim of this study was to screen Han volunteers in Shaanxi for VIP gene polymorphisms.Materials and methodsWe genotyped 80 Very Important Pharmacogenes (VIP) (selected from the PharmGKB database) in 192 unrelated, healthy Han ethnic adults from Shaanxi, the northwest of China, and then analyzed genotyping data wtih Structure and F-statistics (Fst) analysis.ResultsWe compared our data with 15 other populations (Deng, Kyrgyz, Tajik, Uygur and 11 HapMap populations), and found the frequency distribution of Han population in Shaanxi is most similar with CHB. Also, Structure and Fst showed that Shaanxi Han has a closest genetic background with CHB.ConclusionsOur study have supplemented the Han Chinese data related to pharmacogenomics and illustrated differences in genotypic frequencies of selected VIP variants' among the Han population and 15 other populations.